EGRP-Supported Epidemiology Consortia

Breast Cancer


African-American Breast Cancer Consortium

Since 2008
NIH Contacts

EGRP/NCI:

Consortium Liaison:
Damali Martin, Ph.D., M.P.H.

Scientific Consortia Coordinator:
Gabriel Lai, Ph.D.

Lead Investigators:

Chris Haiman, Ph.D.
Norris Comprehensive Cancer Center,
University of Southern California

Funmi Olopade, M.D.
The University of Chicago

Julie Palmer, Sc.D.
Boston University

Asian Breast Cancer Consortium (ABCC)

Since 2008
NIH Contacts

EGRP/NCI:

Scientific Consortia Coordinator and ABCC Liaison:
Gabriel Lai, Ph.D.

Lead Investigator:

Wei Zheng, M.D., Ph.D.
Vanderbilt University School of Medicine
University of Southern California

Breast and Prostate Cancer Cohort Consortium (BPC3)

Since 2003
NIH Contacts

EGRP/NCI:

BPC3 Liaison:
Mukesh Verma, Ph.D.

Scientific Consortia Coordinator:
Gabriel Lai, Ph.D.

DCEG/NCI:

Robert Hoover, M.D., Sc.D.

Lead Investigators:

Susan Gapstur, Ph.D., M.P.H.
American Cancer Society

Brian Henderson, M.D.
University of Southern California

David Hunter, Sc.D.
Channing Laboratory, Harvard University

Elio Riboli, M.D., Sc.M., M.P.H.
Imperial College, London

Breast Cancer and the Environment Research Program (BCERP) Puberty Study

Since 2003
NIH Contacts

Lead Investigators:

Frank Biro, M.D.
Cincinnati Children's Hospital Medical Center

Lawrence Kushi, Sc.D.
Kaiser Foundation Research Institute

Mary Wolff, Ph.D.
Mount Sinai School of Medicine

Coordinating Center:

Robert A. Hiatt, M.D., Ph.D.
University of California San Francisco

Breast Cancer Association Consortium (BCAC)

Since 2005
NIH Contacts

EGRP/NCI:

Scientific Consortia Coordinator &
BCAC Liaison:

Gabriel Lai, Ph.D.

Lead Investigators:

Douglas Easton, Ph.D.
University of Cambridge

Paul Pharoah, Ph.D.
Cambridge Cancer Center

Georgia Chenevix-Trench, Ph.D.
Queensland Institute of Medical Research

Manjeet Humphreys
University of Cambridge

Breast Cancer Consortium for Outcomes and Survival (BC2OS)

Since 2007
NIH Contacts

EGRP/NCI:

Scientific Consortia Coordinator &
BC2OS Liaison:

Gabriel Lai, Ph.D.

OCS/NCI:

Julia Rowland, Ph.D.

Lead Investigators:

Bette Caan, Dr.P.H.
Kaiser Permanente

Xiao Ou Shu, M.D., Ph.D.
Vanderbilt University Medical Center

Breast Cancer Family Registry (B-CFR)

Since 1995
NIH Contacts

EGRP/NCI:

B-CFR Liaison:
Scott Rogers, M.P.H. (for Informatics)

Scientific Consortia Coordinator:
Gabriel Lai, Ph.D.

Lead Investigators:

Irene Andrulis, Ph.D.
Cancer Care Ontario

Saundra Buys, M.D.
University of Utah Health Sciences Center

Mary Daly, M.D., Ph.D.
Fox Chase Cancer Center

John Hopper, Ph.D.
University of Melbourne

Esther John, Ph.D., M.S.P.H.
Cancer Prevention Institute of California

Mary Beth Terry, Ph.D.
Columbia University

Consortium of Contralateral Breast Cancer (CCBC)

Since 2011
NIH Contacts

EGRP/NCI:

Scientific Consortia Coordinator &
CCBC Liaison:

Gabriel Lai, Ph.D.

Lead Investigator:

Jonine Bernstein, Ph.D.
Memorial Sloan-Kettering Cancer Center

The Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Since 2005
NIH Contacts

EGRP/NCI:

Scientific Consortia Coordinator &
CIMBA Liaison:

Gabriel Lai, Ph.D.

Lead Investigators:

Georgia Chenevix-Trench, Ph.D.
Queensland Institute of Medical Research

Douglas Easton, Ph.D.
University of Cambridge

Timothy Rebbeck, Ph.D.
University of Pennsylvania

Evidence-based Network for the Interpretation of Germline Mutant Alleles Consortium (ENIGMA)

Since 2009
NIH Contacts

EGRP/NCI:

Scientific Consortia Coordinator &
ENIGMA Liaison:

Gabriel Lai, Ph.D.

Lead Investigator:

David Goldgar, Ph.D.
University of Utah

Lessons in Epidemiology and Genetics of Adult Cancer from Youth (LEGACY): a Cohort of Youth in Families from the Breast Cancer Family Registry

Since 2011
NIH Contacts

EGRP/NCI:

Scientific Consortia Coordinator &
LEGACY Liaison:

Gabriel Lai, Ph.D.

Lead Investigators:

Esther M. John, Ph.D., M.S.P.H.
Cancer Prevention Institute of California

Mary Beth Terry, Ph.D.
Columbia University Medical Center

Mary B. Daly, M.D., Ph.D.
Fox Chase Cancer Center

Irene L. Andrulis, Ph.D.
Samuel Lunenfeld Research Institute, Mt. Sinai Hospital

Saundra Buys, M.D.
Huntsman Cancer Institute

Prevention and Observation of Surgical Endpoints and Modifiers of Cancer Risk in BRCA 1/2 Mutation Carriers (PROSE-Modifiers Studies) (Collaborative Studies of BRCA 1/2 Mutation Carriers)

NIH Contacts

EGRP/NCI:

Scientific Consortia Coordinator &
PROSE Liaison:

Gabriel Lai, Ph.D.

Lead Investigators:

Timothy Rebbeck, Ph.D.
University of Pennsylvania

Women, Cancer and Radiation Exposure (WECARE)

Since 2002
NIH Contacts

EGRP/NCI:

Scientific Consortia Coordinator &
WECARE Liaison:

Gabriel Lai, Ph.D.

Lead Investigators:

Jonine Bernstein, Ph.D.
Memorial Sloan-Kettering Cancer Center

Key to Acronyms Used in Tables

  • EGRP - Epidemiology and Genomics Research Program
  • CDC - Centers for Disease Control and Prevention
  • DCB - Division of Cancer Biology
  • DCEG - Division of Cancer Epidemiology and Genetics
  • NCI - National Cancer Institute
  • NHGRI - National Human Genome Research Institute
  • NIEHS - National Institute of Environmental Health Sciences
  • NIGMS - National Institute of General Medical Sciences
  • NIH - National Institutes of Health
  • OCS - Office of Cancer Survivorship
  • OD - Office of the Director

Return to Top